Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Galmozzi

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|November 23, 2019
Letter to the Editor: Does the HSD17B13 rs72613567 Splice Variant Actually Yield a New Type of Alternative Splicing?Enrico Galmozzi
Journal of Hepatology|January 31, 2012
Genetic testing for hepatocellular carcinoma: an ambitious goal still to achieveEnrico Galmozzi, Massimo Colombo
Hepatology (Baltimore, Md.)|December 26, 2015
Do ITPA gene variants provide insight to detecting patients infected with HCV 2/1 recombinant strains?Enrico Galmozzi, Roberta D'Ambrosio
Hepatobiliary Surgery and Nutrition|July 27, 2018
Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?Enrico Galmozzi, Roberta D'Ambrosio
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2014
Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patientsEnrico Galmozzi, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null respondersEnrico Galmozzi, Alessio Aghemo, Massimo Colombo
Hepatology (Baltimore, Md.)|June 19, 2012
[Not Available]Pietro Lampertico, Enrico Galmozzi, Massimo Colombo
Journal of Hepatology|January 31, 2012
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipientsMaria Francesca Donato, Enrico Galmozzi, Cristina Rigamonti, et al.
Hepatology (Baltimore, Md.)|June 30, 2012
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?Enrico Galmozzi, Stella De Nicola, Alessio Aghemo, et al.
Journal of Cellular Physiology|July 16, 2004
Role of HER receptors family in development and differentiationPatrizia Casalini, Marilena V Iorio, Enrico Galmozzi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|November 23, 2019
Letter to the Editor: Does the HSD17B13 rs72613567 Splice Variant Actually Yield a New Type of Alternative Splicing?Enrico Galmozzi
Journal of Hepatology|January 31, 2012
Genetic testing for hepatocellular carcinoma: an ambitious goal still to achieveEnrico Galmozzi, Massimo Colombo
Hepatology (Baltimore, Md.)|December 26, 2015
Do ITPA gene variants provide insight to detecting patients infected with HCV 2/1 recombinant strains?Enrico Galmozzi, Roberta D'Ambrosio
Hepatobiliary Surgery and Nutrition|July 27, 2018
Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?Enrico Galmozzi, Roberta D'Ambrosio
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2014
Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patientsEnrico Galmozzi, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null respondersEnrico Galmozzi, Alessio Aghemo, Massimo Colombo
Hepatology (Baltimore, Md.)|June 19, 2012
[Not Available]Pietro Lampertico, Enrico Galmozzi, Massimo Colombo
Journal of Hepatology|January 31, 2012
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipientsMaria Francesca Donato, Enrico Galmozzi, Cristina Rigamonti, et al.
Hepatology (Baltimore, Md.)|June 30, 2012
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?Enrico Galmozzi, Stella De Nicola, Alessio Aghemo, et al.
Journal of Cellular Physiology|July 16, 2004
Role of HER receptors family in development and differentiationPatrizia Casalini, Marilena V Iorio, Enrico Galmozzi, et al.
Pageof 4